Clinical Trials Browser

INDUSTRY × Advanced Solid Tumor × Ramucirumab × Clear all

NCT04557384 2023-02-27

A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer

Phase 1 Terminated

3 enrolled 9 charts

Other solid neoplasm

Advanced Solid Tumor